Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma
Recruiting now · Phase 2
Conditions studied: Indolent B-Cell Non-Hodgkin Lymphoma
In brief
This study explores the efficacy of Ga-68-PentixaFor PET/CT in detecting, assessing treatment response, and monitoring the risk of aggressiveness in indolent B-cell lymphoma. The background introduces CXCR4 and discusses its role in cancer research. Currently, FDG-PET is the primary imaging tool for lymphoma staging, but it lacks diagnostic accuracy for low-grade lymphomas. Ga-68-PentixaFor PET demonstrates promising detection capabilities across various lymphomas, suggesting its potential as a superior imaging modality for low-grade lymphomas.
Key facts
- Study ID
- NCT06461182
- Run by
- Koo Foundation Sun Yat-Sen Cancer Center
- People needed
- 15
- Starts
- 2024-04-29
- Expected to finish
- 2027-04-01
- Last updated by the study team
- 2024-06-14
Who can join
Age: 20 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The pathological diagnosis is slow-growing lymphoma, such as: marginal-zone B-cell lymphoma, Waldenstrom macroglobulinemia lymphocytic lymphoma, CLL/SLL, mantle cell lymphoma.
- Have undergone or planned to undergo FDG PET scan for indications including initial staging, therapeutic response evaluation, or follow-up examinations within 3 to 6 months in the clinical observation group.
- Able to lie flat for at least 30 minutes.
- Signing the subject consent form.
- ECOG grade 0-2.
- The timing of F-18-FDG usage in this trial follows the "Lymphoma Treatment Principles" of our institution.
You may not qualify if…
- Pregnant woman
- Severe renal impairment (eGRF< 30ml/min)
- Known or suspected allergy to radiopharmaceuticals
- Concurrent or previous diagnosis of malignancies other than lymphoma
- Inability to undergo the necessary PET scan procedure
- Refusal or unwillingness to sign the informed consent form
- Severe medical conditions (severe disabilities, mental disorders)
Where it is running
- Koo Foundation Sun Yat-Sen Cancer Center — Taipei, Beitou, Taiwan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.